Apellis Pharmaceuticals (APLS) PT Lowered to $26 at Wells Fargo
Tweet
Share
E-mailGet Alerts APLS Hot Sheet
Price: $41.03 --0%
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 9
Rating Summary:
6 Buy, 23 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 9
Join SI Premium – FREE
Wells Fargo analyst Derek Archila lowered the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $26.00 (from $29.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yeti Holdings Inc. (YETI) PT Raised to $45 at Stifel on Beat and Raise Q2 Results
- CESC Ltd (CESC:IN) PT Lowered to INR200 at Nuvama
- Jubilant Foodworks Ltd (JUBI:IN) PT Raised to INR668 at Nuvama
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
